News for Xiaomi Corporation (3CP.SG)

The U.S. banned Chinese smartphone major Xiaomi Corp (OTC: XIACF) (OTC: XIACY) over alleged military ties triggered by an award given to ...

The governance structure used by companies such as Facebook, Alibaba and Volkswagen is going global, and not everyone is happy. Dual-class shares, as they’re known, give company founders super-sized power over their businesses even if they only hold a small slice of the stock. While the formula is popular, especially among technology firms -- it blends public shares with the private-equity model -- many investors bristle at its undemocratic nature. Adoption of the structure by exchanges in Londo

The Defense Department labeled smartphone maker Xiaomi as a company that supports China’s military partly due to an award given to its founder for his service to the state, along with Xiaomi’s ambitious investment plans in advanced technologies such as 5G and artificial intelligence.

The changes take effect from March 12, FTSE Russell said in a statement, citing the order. It added that the deletions were subject to further guidance from the US Office of Foreign Assets Control.

1. What’s the case against dual-class shares? Opponents say they subvert the one-share, one-vote principal designed to give equal treatment to all shareholde...

Many audio apps similar to Clubhouse are being launched in China. Some users were paying $60 for Clubhouse invites before Beijing banned the platform.

The governance structure used by companies such as Facebook, Alibaba and Volkswagen is going global, and not everyone is happy. Dual-class shares, as they’re known, give company founders super-sized power over their businesses even if they only hold a small slice of the stock. While the formula is popular, especially among technology firms -- it blends public shares with the private-equity model -- many investors bristle at its undemocratic nature. Adoption of the structure by exchanges in Londo

Huawei Technologies Co is planning to manufacture electric cars under its own brand, Reuters reported, as it shifts away from a consumer electronics business…

Xiaomi also makes phones at plants in India run by contract manufacturers Foxconn Technology Co and Flex Ltd

Carmakers from Tokyo to Detroit are slashing production. PlayStations are getting harder to find in stores. Even aluminum producers warn of a potential downturn ahead. All have one thing in common: an abrupt and cascading global shortage of semiconductors. Semiconductors, also known as integrated circuits or more commonly just chips, may be the tiniest yet most exacting product ever manufactured on a global scale. That level of cost and difficulty has fostered a growing worldwide dependence on t

Kuaishou soared in its Hong Kong debut, the latest Chinese tech company to shun U.S. exchanges and stay closer to home.

gaitQ Provides Business Update Recent fundraising to support early testing of Parkinson’s system in a clinical studySupport received from Parkinson’s UK Progress in user recruitment for clinical study Oxford, UK, 9 February 2021 – gaitQ, a spin-out from the University of Oxford which is developing a wearable, smart medical device that helps those with Parkinson’s overcome gait freezing episodes, is pleased to announce a business update on its recent and ongoing activities since launching in March 2020. Funding Since its inception in 2020, the company has made significant progress towards the development of the gaitQ system after attracting GBP 625,000 in pre-seed capital from both the University of Oxford Innovation Fund V, managed by Parkwalk Advisors, and via a private investment from Simon Godwin, recently appointed Chairman of gaitQ. Proceeds from the financing are being used to advance the early testing and development of gaitQ’s device. Parkinson’s UK Parkinson’s UK has confirmed they will continue to support the development of gaitQ by facilitating patient and public involvement activities. The organisation, Europe’s largest charitable funder of Parkinson’s research, will help to build gaitQ’s increasing network and advise on how the Company can engage with people with Parkinson’s, their carers, clinicians and other key stakeholders. Natasha Ratcliffe, Research Involvement Manager at Parkinson’s UK, said: “People with Parkinson’s are at the heart of all the work we do and their invaluable experiences and insights are helping to shape all forms of pioneering research. We’re really pleased to support gaitQ to involve the Parkinson’s community as they develop a device to overcome mobility issues.” “Freezing is one of the most distressing yet least known symptoms of Parkinson's, and a recent survey we carried out highlighted that this issue becomes increasingly important to people as the condition progresses. Innovative technologies like the gaitQ system that could reduce freezing episodes hold real promise to significantly improve the quality of life for 145,000 people living with Parkinson’s in the UK, giving them more freedom to enjoy daily activities.” User recruitment gaitQ is recruiting individuals with Parkinson’s for a study investigating the use of a range of device capabilities, in a clinical setting. The gaitQ system will include functionality to deliver personalized, adaptive cueing for people with Parkinson’s experiencing gait-freezing in a discreet, unobtrusive device. Data collected using the gaitQ system will accurately reflect the episodes of gait freezing symptoms and walking quality over time to allow the progression of the condition to be tracked. In the future, data from the gaitQ system could help clinicians optimize medication delivery or be provided to pharma companies as real-world evidence in developing new treatment options. Tristan Collins, CEO of gaitQ, said: “The last year has been very important for gaitQ and we are pleased to have made significant progress towards the development of our system despite the challenging COVID-19 environment that we are operating in. The investment, combined with the continued support from Parkinson’s UK, enhances the credibility and integrity of gaitQ and will help us achieve our mission of improving mobility in people with Parkinson’s. We are thankful for the continued support of our shareholders and are looking forward to receiving clinical validation from the upcoming clinical study which will take us to the next step in our development.” Simon Godwin, Chairman of gaitQ, said: “I am very proud of the gaitQ team who have continued to drive forward the company which was spun out of the University of Oxford at the beginning of the COVID-19 crisis. I am excited about the year ahead as the company continues to grow from strength to strength.” About gaitQ gaitQ is a spinout from the University of Oxford developing a wearable, smart medical device aimed at restoring mobility in people with Parkinson’s. Around 45% of people with Parkinson’s eventually develop gait-freezing, an intermittent failure to initiate or maintain walking – often described as the most debilitating symptom of the condition1. gaitQ’s first product will be a cueing device that helps individuals overcome gait-freezing episodes and maintain their levels of activity for longer. gaitQ features personalised, adaptive cueing during periods of gait-freezing in a discrete, unobtrusive device. Powered by proprietary machine learning algorithms, gaitQ’s technology has been in development for more than three years within Oxford University’s Institute of Biomedical Engineering (IBME) and the Department of Physiology Anatomy & Genetics (DPAG). A recent clinical study has demonstrated preliminary efficacy results showing a reduction in gait freezing events of 55%, a reduction of freeze duration of 73%, and an overall improvement in walking metrics. Find out more at https://www.gaitq.com/ About Parkinson’s and Parkinson’s UK Parkinson’s is what happens when the brain cells that make dopamine start to die. There are more than 40 symptoms, from tremor and pain to anxiety. Some are treatable, but the drugs can have serious side effects. It gets worse over time and there’s no cure. Yet. Parkinson’s is the fastest growing neurological condition in the world. Around 145,000 people in the UK have Parkinson’s. For more facts and statistics, please click here. Further information, advice and support is available on our website, www.parkinsons.org.uk. For more information please contact: gaitQ Tristan Collins [email protected] Consilium Strategic Communications Mary-Jane Elliott / Alexandra Harrison / Davide Salvi [email protected] Tel: +44 (0) 20 3709 5700 1 https://www.ncbi.nlm.nih.gov/pubmed/22795382

Dialog is the latest U.K.-based chip maker to be targeted by overseas bidders after Nvidia's $40 billion takeover of Arm Holdings.

UBS analyzed some of China's largest tech companies and chose the stocks most likely to benefit — and suffer — from potential shocks.

Major indices worldwide traded higher on Thursday as President Joe Biden taking office on Wednesday restored investor optimism of a more significant ...